BLCM News and Press, Bellicum Pharmaceuticals Inc.

Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...

First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...

2024-02-22 18:05:51 ET More on Bellicum Pharmaceuticals Financial information for Bellicum Pharmaceuticals Read the full article on Seeking Alpha For further details see: Bellicum sells assets to MD Anderson, moves towards liquidation

Kajima Corporation ADR (KAJMY) is expected to report for quarter end 2023-12-31 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 BrewBilt MFG Inc (BBRW) is expected to report for Q4 2023 Correlate Energy Corp. (CIPI) is expected to report for Q4 2023 Hyzon Motors Inc. (...

ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

Bellicum Pharmaceuticals Inc. (BLCM) is expected to report for Q3 2023

2023-05-08 09:01:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tupperware Brands (NYSE: TUP ) stock is taking a beating on Monday after the company said it’s exploring strategic alternatives . A filing with the Securities and...

2023-05-08 08:43:57 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aptorum (NASDAQ: APM ) stock is falling on Monday after the biopharmaceutical company received a delisting notice from the Nasdaq . The reason given for the delistin...

2023-05-08 08:19:51 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Immuron (NASDAQ: IMRN ) stock is gaining on Monday thanks to an update from the Food and Drug Administration (FDA) on a clinical hold. The FDA has lifted a clinical hold ...